Overview
?
Roch Doliveux
See more contacts
Business Support Services
,
Pharmaceutical and Medicine Manufacturing
,
Administrative and Support Services
,
Administrative and Support and Waste Management and Remediation Services
,
Business services, nec
See All Industries , Pharmaceutical preparations Holding companies, nec
See Fewer Industries
See All Industries , Pharmaceutical preparations Holding companies, nec
See Fewer Industries
Employment Services
,
Facilities Support Services
,
Investigation and Security Services
,
Office Administrative Services
,
Other Support Services
,
Remediation and Other Waste Management Services
,
Services to Buildings and Dwellings
,
Travel Arrangement and Reservation Services
View more , Waste Collection Waste Treatment and Disposal
View fewer
View more , Waste Collection Waste Treatment and Disposal
View fewer
?
?
?
Actual
?
Estimated
$7.00 billion
Actual
17.14%
210.5%
$17,347
?
?
BSE:UCB
Contacts
Get in Touch with 16 Principals*
-
Roch DoliveuxDirector
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue
$7.00 billion
USD
Modelled
1 USD = 0.8785 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $1,414 | $866 | $1,274 |
| Net Investing Cash | $321 | -$501 | -$1,799 |
| Net Financing Cash | -$931 | -$351 | $80 |
| Net Change in Cash | $804 | $15 | -$445 |
| Cash at Beginning of Period | $980 | $978 | $1,416 |
| Cash at End of Period | $1,791 | $980 | $978 |
| Capital Expenditure | -$367 | -$360 | -$422 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $1,791 | $980 | $1,023 |
| Accounts Receivable | $1,147 | $854 | $782 |
| Inventories | $1,490 | $1,174 | $1,032 |
| Other Current Assets | $1,022 | $913 | $923 |
| Asset Summary | |||
| Total Current Assets | $5,450 | $3,920 | $3,761 |
| Tangible Fixed Assets | $1,997 | $1,816 | $1,632 |
| Intangible Assets | $4,647 | $4,817 | $5,482 |
| Total Assets | $17,347 | $15,539 | $15,868 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $854 | $611 | $652 |
| Short-Term Debt | $2 | -$1 | $253 |
| Other Current Liabilities | $3,161 | $2,368 | $2,637 |
| Liability Summary | |||
| Total Current Liabilities | $4,017 | $2,978 | $3,542 |
| Long-Term Debt | $3,208 | $3,276 | $2,889 |
| Other Long-Term Liabilities | $1 | $ | $ |
| Total Liabilities | $8,330 | $7,472 | $7,745 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $665 | $665 | $665 |
| Retained Earnings | $8,418 | $7,488 | $7,336 |
| Equity Summary | |||
| Total Equity | $11,416 | $10,216 | $10,318 |
| Shares Outstanding | 190,042,407 | 189,776,569 | 189,594,898 |